US Stock MarketDetailed Quotes
KYTX Kyverna Therapeutics
- 4.390
- +0.400+10.03%
Close Nov 22 16:00 ET
- 4.380
- -0.010-0.23%
Post 20:01 ET
189.52MMarket Cap-1712P/E (TTM)
4.420High3.920Low270.31KVolume4.000Open3.990Pre Close1.15MTurnover1.21%Turnover RatioLossP/E (Static)43.17MShares35.06052wk High0.63P/B98.22MFloat Cap3.92052wk Low--Dividend TTM22.37MShs Float35.060Historical High--Div YieldTTM12.53%Amplitude3.920Historical Low4.250Avg Price1Lot Size
About Kyverna Therapeutics Company
Kyverna Therapeutics, Inc. is a cell therapy clinical-stage biotechnology company. It develops treatments and potential cures for serious autoimmune diseases. The company was founded in June 2018 and is headquartered in Emeryville, CA.
Company Profile
SymbolKYTX
Company NameKyverna Therapeutics
Listing DateFeb 8, 2024
Issue Price22.00
CEOMr. Warner Weston Biddle
MarketNASDAQ
Employees96
Fiscal Year Ends12-31
Address5980 Horton Street,Suite 550
CityEmeryville
ProvinceCalifornia
CountryUnited States of America
Zip Code94608
Phone1-510-925-2492
Websitehttp://www.kyvernatx.com
Company Executives
- Name
- Position
- Salary
- Warner Weston Biddle
- Chief Executive Officer and Director
- --
- Karen Walker
- Chief Technology Officer
- 1.08M
- Ryan Jones
- Chief Financial Officer
- --
- Ian T. Clark
- Chairman of the Board
- 306.74K
- Dominic Borie, M.D.
- President, Research and Development
- --
- Christi Shaw
- Director
- --
- Dr. Beth C. Seidenberg,M.D.
- Independent Director
- 155.05K
- Daniel K. Spiegelman
- Independent Director
- 245.05K
- Dr. Steve Liapis, PhD
- Independent Director
- --
- Mert Aktar
- Independent Director
- --
- Dr. Fred E. Cohen, D.Phil.,F.A.C.P.,M.D.
- Independent Director
- 155.05K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
